Piper Sandler analyst Brent Bracelin maintained an Overweight rating on HubSpot Inc HUBS with a $570 price target. Bracelin expects HubSpot to gain market share due to its highly efficient GTM effort combined with organic product development, which results in customer satisfaction and structurally higher gross dollar retention in the high 80s. The analyst noted that … Read more
Endava PLC DAVA came out with quarterly earnings of $0.28 per share, missing the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.71 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -3.45%. A quarter ago, it was expected that this … Read more
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Considering buying ABT stock? Here’s what analysts think: Read Next: Market News and Data brought to you by Benzinga APIs © 2024 Benzinga.com. Benzinga does … Read more
Throughout the last three months, 4 analysts have evaluated Editas Medicine EDIT, offering a diverse set of opinions from bullish to bearish. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish … Read more
Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage — “buy low and sell high.” Investors following this investing style typically avoid betting on cheap stocks and waiting long for them to recover. They believe instead that one could make far more money in lesser time by “buying high and selling higher.” … Read more
Thursday, Moderna Inc MRNA unveiled key updates at its annual R&D Day by reducing annual R&D spending by $1.1 billion by 2027, enabling a focus on ten prioritized products. The company expects R&D expenses to fall from $4.8 billion in 2024E to $3.6 billion—$3.8 billion in 2027. The strategy, expanding its portfolio into oncology and rare diseases, positions … Read more
Tesla Inc TSLA could have an exciting October to remember with third-quarter earnings, third-quarter deliveries and its Robotaxi Day. An analyst said investors should focus on deliveries before robotaxis. The Tesla Analyst: Canaccord Genuity analyst George Gianarikas has a Buy rating with a $254 price target on Tesla. Read Also: Tesla Patent Shows New Automotive … Read more
Launched on 04/19/2011, the First Trust Small Cap Growth AlphaDEX ETF FYC is a passively managed exchange traded fund designed to provide a broad exposure to the Small Cap Growth segment of the US equity market. The fund is sponsored by First Trust Advisors. It has amassed assets over $314.36 million, making it one of … Read more
Software company Adobe Inc ADBE could provide another example of a company utilizing artificial intelligence for new products and financial growth when the company reports third-quarter financial results after market close Thursday. Earnings Estimates: Analysts expect Adobe to report third-quarter revenue of $5.37 billion. That’s up from $4.89 billion in last year’s third quarter, according … Read more
Bank of America has reshuffled its sector outlooks, raising Utilities to “overweight” while downgrading Energy to “market-weight.” The changes come as elevated volatility and policy uncertainty drive a recalibration of investment strategies. According to Savita Subramanian, Bank of America’s head of U.S. equity strategy, the shifting economic and political landscape has altered the risk-reward profiles … Read more
